JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M209564200 on October 2, 2002

J. Biol. Chem., Vol. 277, Issue 51, 49167-49174, December 20, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/51/49167    most recent
M209564200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Papineni, R. V. L.
Right arrow Articles by Hamilton, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Papineni, R. V. L.
Right arrow Articles by Hamilton, S. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Suramin Interacts with the Calmodulin Binding Site on the Ryanodine Receptor, RYR1*

Rao V. L. PapineniDagger , Kristen M. S. O'Connell§, Hongwei ZhangDagger , Robert T. Dirksen§, and Susan L. HamiltonDagger

From the Dagger  Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas 77030 and § Department of Pharmacology and Physiology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

Apocalmodulin and Ca2+ calmodulin bind to overlapping sites on the ryanodine receptor skeletal form, RYR1, but have opposite functional effects on channel activity. Suramin, a polysulfonated napthylurea, displaces both forms of calmodulin, leading to an inhibition of activity at low Ca2+ and an enhancement of activity at high Ca2+. Calmodulin binding motifs on RYR1 are also able to directly interact with the carboxy-terminal tail of the transverse tubule dihydropyridine receptor (DHPR) (Sencer, S., Papineni, R. V., Halling, D. B., Pate, P., Krol, J., Zhang, J. Z., and Hamilton, S. L. (2001) J. Biol. Chem. 276, 38237-38241). Suramin binds directly to a peptide that corresponds to the calmodulin binding site of RYR1 (amino acids 3609-3643) and blocks the interaction of this peptide with both calmodulin and the carboxyl-terminal tail of the DHPR alpha 1-subunit. Suramin, added to the internal solution of voltage-clamped skeletal myotubes, produces a concentration-dependent increase in the maximal magnitude of voltage-gated Ca2+ transients without significantly altering L-channel Ca2+ channel conducting activity. Together, these results suggest that an interaction between the carboxyl-terminal tail of the DHPR alpha 1-subunit with the calmodulin binding region of RYR1 serves to limit sarcoplasmic reticulum Ca2+ release during excitation-contraction coupling and that suramin-induced potentiation of voltage-gated Ca2+ release involves a relief of this inhibitory interaction.


* This work was supported by grants from the Muscular Dystrophy Association (to S. L. H.) and National Institutes of Health Grants AR44864 and AR41802 (to S. L. H.) and AR44657 (to R. T. D.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 713-798-3894; Fax: 713-798-5441; E-mail: susanh@bcm.tmc.edu.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
N. Nadif Kasri, G. Bultynck, J. B. Parys, G. Callewaert, L. Missiaen, and H. De Smedt
Suramin and Disulfonated Stilbene Derivatives Stimulate the Ca2+-Induced Ca2+-Release Mechanism in A7r5 Cells
Mol. Pharmacol., July 1, 2005; 68(1): 241 - 250.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. M. Rossi and C. W. Taylor
Ca2+ Regulation of Inositol 1,4,5-trisphosphate Receptors: Can Ca2+ Function without Calmodulin?
Mol. Pharmacol., August 1, 2004; 66(2): 199 - 203.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. N. Kasri, G. Bultynck, J. Smyth, K. Szlufcik, J. B. Parys, G. Callewaert, L. Missiaen, R. A. Fissore, K. Mikoshiba, and H. de Smedt
The N-terminal Ca2+-Independent Calmodulin-Binding Site on the Inositol 1,4,5-trisphosphate Receptor Is Responsible for Calmodulin Inhibition, Even Though This Inhibition Requires Ca2+
Mol. Pharmacol., August 1, 2004; 66(2): 276 - 284.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. P. Hill, O. Kingston, and R. Sitsapesan
Functional Regulation of the Cardiac Ryanodine Receptor by Suramin and Calmodulin Involves Multiple Binding Sites
Mol. Pharmacol., May 1, 2004; 65(5): 1258 - 1268.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.